Zhejiang Wecome Pharmaceutical Management
Management criteria checks 3/4
Zhejiang Wecome Pharmaceutical's CEO is Xiaoxia Kong, appointed in May 2021, has a tenure of 3.58 years. directly owns 0.63% of the company’s shares, worth CN¥15.22M. The average tenure of the management team and the board of directors is 3.6 years and 3.6 years respectively.
Key information
Xiaoxia Kong
Chief executive officer
CN¥1.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 3.6yrs |
| CEO ownership | 0.6% |
| Management average tenure | 3.6yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 39%
Oct 09
Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) Investors Are Less Pessimistic Than Expected
Aug 02Subdued Growth No Barrier To Zhejiang Wecome Pharmaceutical Company Limited (SZSE:300878) With Shares Advancing 29%
Mar 08CEO
Xiaoxia Kong (42 yo)
3.6yrs
Tenure
CN¥1,001,900
Compensation
Ms. Xiaoxia Kong serves as General Manager at Zhejiang Wecome Pharmaceutical Company Limited since May 17, 2021 and has been its Director since May 17, 2021 and was its Deputy General Manager until May 17,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 3.6yrs | CN¥1.00m | 0.63% CN¥ 15.2m | |
| Finance Director | 3.6yrs | CN¥219.60k | no data | |
| Deputy GM & Non-Independent Director | 3.6yrs | CN¥299.80k | no data | |
| Secretary & Non-Independent Director | 3.6yrs | CN¥219.90k | no data | |
| Deputy General Manager | 9.8yrs | CN¥266.90k | 0.25% CN¥ 6.0m | |
| Deputy General Manager | 3.6yrs | CN¥269.10k | no data |
3.6yrs
Average Tenure
46yo
Average Age
Experienced Management: 300878's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 3.6yrs | CN¥1.00m | 0.63% CN¥ 15.2m | |
| Deputy GM & Non-Independent Director | 3.6yrs | CN¥299.80k | no data | |
| Secretary & Non-Independent Director | 3.6yrs | CN¥219.90k | no data | |
| Independent Director | 2.2yrs | CN¥80.00k | no data | |
| Chairman of the Board | 9.8yrs | CN¥980.00k | 69.01% CN¥ 1.7b | |
| Chairman of the Supervisory Board | 9.8yrs | no data | no data | |
| Non-Employee Supervisor | 8.8yrs | no data | no data | |
| Independent Director | 3.6yrs | CN¥80.00k | no data | |
| Supervisor | 9.8yrs | no data | no data | |
| Independent Director | 3.6yrs | CN¥80.00k | no data |
3.6yrs
Average Tenure
47yo
Average Age
Experienced Board: 300878's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 17:45 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhejiang Wecome Pharmaceutical Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|